Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | AGIO |
---|---|---|
09:32 ET | 97672 | 42.58 |
09:36 ET | 600 | 42.595 |
09:38 ET | 4364 | 43.44 |
09:39 ET | 848 | 43.35 |
09:41 ET | 5641 | 43.75 |
09:43 ET | 300 | 43.87 |
09:45 ET | 400 | 43.56 |
09:48 ET | 11165 | 44.15 |
09:50 ET | 9546 | 44.435 |
09:52 ET | 3258 | 44.145 |
09:54 ET | 3159 | 44.04 |
09:56 ET | 900 | 43.85 |
09:57 ET | 4425 | 43.7 |
09:59 ET | 489 | 43.9 |
10:01 ET | 800 | 43.98 |
10:03 ET | 2862 | 43.99 |
10:06 ET | 100 | 43.985 |
10:08 ET | 500 | 44.15 |
10:10 ET | 3074 | 44.14 |
10:12 ET | 1137 | 44.125 |
10:14 ET | 802 | 44 |
10:15 ET | 2566 | 44.15 |
10:17 ET | 1055 | 44.2615 |
10:19 ET | 1990 | 44.47 |
10:21 ET | 725 | 44.575 |
10:24 ET | 1810 | 44.51 |
10:26 ET | 2918 | 44.46 |
10:28 ET | 1300 | 44.54 |
10:30 ET | 700 | 44.6 |
10:32 ET | 2405 | 44.505 |
10:33 ET | 700 | 44.45 |
10:37 ET | 1200 | 44.56 |
10:39 ET | 2600 | 44.27 |
10:42 ET | 600 | 44.2 |
10:44 ET | 3405 | 44.36 |
10:46 ET | 200 | 44.19 |
10:50 ET | 700 | 44.44 |
10:51 ET | 1311 | 44.43 |
10:53 ET | 600 | 44.39 |
10:55 ET | 1442 | 44.265 |
10:57 ET | 400 | 44.13 |
11:00 ET | 1185 | 44.12 |
11:02 ET | 500 | 44.17 |
11:04 ET | 900 | 44.02 |
11:06 ET | 500 | 44 |
11:08 ET | 800 | 44.045 |
11:09 ET | 300 | 44.02 |
11:11 ET | 829 | 43.96 |
11:13 ET | 1806 | 43.95 |
11:15 ET | 700 | 44.01 |
11:18 ET | 800 | 44.11 |
11:20 ET | 2612 | 44.17 |
11:22 ET | 1313 | 44.22 |
11:24 ET | 2983 | 44.42 |
11:26 ET | 1300 | 44.38 |
11:27 ET | 700 | 44.29 |
11:29 ET | 312 | 44.415 |
11:31 ET | 959 | 44.47 |
11:33 ET | 1052 | 44.47 |
11:36 ET | 700 | 44.52 |
11:38 ET | 1104 | 44.53 |
11:40 ET | 945 | 44.42 |
11:42 ET | 300 | 44.44 |
11:44 ET | 800 | 44.29 |
11:45 ET | 509 | 44.225 |
11:47 ET | 100 | 44.11 |
11:49 ET | 1000 | 44.22 |
11:51 ET | 601 | 44.29 |
11:54 ET | 1000 | 44.34 |
11:56 ET | 700 | 44.24 |
11:58 ET | 600 | 44.285 |
12:00 ET | 500 | 44.33 |
12:02 ET | 204 | 44.39 |
12:03 ET | 1300 | 44.47 |
12:05 ET | 900 | 44.38 |
12:07 ET | 701 | 44.45 |
12:09 ET | 300 | 44.43 |
12:12 ET | 400 | 44.395 |
12:14 ET | 1200 | 44.46 |
12:16 ET | 1300 | 44.37 |
12:18 ET | 200 | 44.3505 |
12:20 ET | 600 | 44.305 |
12:21 ET | 1801 | 44.53 |
12:23 ET | 500 | 44.53 |
12:25 ET | 300 | 44.495 |
12:27 ET | 1398 | 44.41 |
12:30 ET | 225 | 44.37 |
12:32 ET | 1000 | 44.48 |
12:34 ET | 500 | 44.54 |
12:36 ET | 1500 | 44.435 |
12:38 ET | 1088 | 44.42 |
12:39 ET | 245 | 44.465 |
12:41 ET | 500 | 44.49 |
12:43 ET | 500 | 44.49 |
12:45 ET | 2726 | 44.475 |
12:48 ET | 600 | 44.495 |
12:50 ET | 108 | 44.49 |
12:52 ET | 500 | 44.57 |
12:54 ET | 1666 | 44.68 |
12:56 ET | 1400 | 44.675 |
12:57 ET | 500 | 44.66 |
12:59 ET | 1300 | 44.73 |
01:01 ET | 1482 | 44.64 |
01:03 ET | 600 | 44.64 |
01:06 ET | 697 | 44.61 |
01:08 ET | 1100 | 44.554 |
01:10 ET | 2036 | 44.64 |
01:12 ET | 500 | 44.65 |
01:14 ET | 100 | 44.605 |
01:15 ET | 100 | 44.63 |
01:17 ET | 500 | 44.58 |
01:19 ET | 652 | 44.56 |
01:21 ET | 500 | 44.52 |
01:24 ET | 800 | 44.62 |
01:26 ET | 5068 | 44.86 |
01:28 ET | 1330 | 44.9 |
01:30 ET | 800 | 44.91 |
01:32 ET | 600 | 44.92 |
01:33 ET | 600 | 44.96 |
01:35 ET | 620 | 45.12 |
01:37 ET | 2800 | 45.04 |
01:39 ET | 400 | 44.99 |
01:42 ET | 16407 | 44.95 |
01:44 ET | 800 | 44.915 |
01:46 ET | 700 | 44.98 |
01:48 ET | 200 | 45 |
01:50 ET | 500 | 45.11 |
01:51 ET | 2181 | 45.19 |
01:53 ET | 1256 | 45.16 |
01:55 ET | 800 | 45.24 |
01:57 ET | 500 | 45.25 |
02:00 ET | 700 | 45.26 |
02:02 ET | 1935 | 45.03 |
02:04 ET | 1900 | 44.99 |
02:06 ET | 1100 | 44.89 |
02:08 ET | 400 | 44.84 |
02:09 ET | 1198 | 44.74 |
02:11 ET | 2400 | 44.94 |
02:13 ET | 500 | 45 |
02:15 ET | 700 | 45.01 |
02:18 ET | 3355 | 44.94 |
02:20 ET | 707 | 44.915 |
02:22 ET | 900 | 44.82 |
02:24 ET | 700 | 44.71 |
02:26 ET | 1406 | 44.795 |
02:27 ET | 1313 | 44.88 |
02:29 ET | 1142 | 44.8 |
02:33 ET | 1458 | 44.63 |
02:36 ET | 1312 | 44.57 |
02:38 ET | 3250 | 44.79 |
02:40 ET | 758 | 44.705 |
02:42 ET | 1151 | 44.74 |
02:44 ET | 2845 | 44.68 |
02:45 ET | 1176 | 44.76 |
02:47 ET | 2258 | 44.8 |
02:49 ET | 1246 | 44.76 |
02:51 ET | 300 | 44.805 |
02:54 ET | 650 | 44.77 |
02:56 ET | 1859 | 44.7 |
02:58 ET | 1147 | 44.78 |
03:00 ET | 1856 | 44.725 |
03:02 ET | 1435 | 44.62 |
03:03 ET | 1322 | 44.62 |
03:05 ET | 952 | 44.72 |
03:07 ET | 1757 | 44.66 |
03:09 ET | 1662 | 44.65 |
03:12 ET | 3519 | 44.68 |
03:14 ET | 1567 | 44.73 |
03:16 ET | 2015 | 44.58 |
03:18 ET | 2705 | 44.69 |
03:20 ET | 1028 | 44.66 |
03:21 ET | 1750 | 44.57 |
03:23 ET | 500 | 44.66 |
03:25 ET | 1646 | 44.495 |
03:27 ET | 805 | 44.51 |
03:30 ET | 2011 | 44.56 |
03:32 ET | 4512 | 44.31 |
03:34 ET | 3359 | 44.155 |
03:36 ET | 5776 | 44.03 |
03:38 ET | 6641 | 44.06 |
03:39 ET | 3806 | 44.14 |
03:41 ET | 2425 | 44.145 |
03:43 ET | 169794 | 44.24 |
03:45 ET | 8943 | 44.52 |
03:48 ET | 8975 | 44.57 |
03:50 ET | 4164 | 44.45 |
03:52 ET | 8955 | 44.495 |
03:54 ET | 12649 | 44.545 |
03:56 ET | 38499 | 44.97 |
03:57 ET | 18896 | 45.014 |
03:59 ET | 1597078 | 45.22 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Agios Pharmaceuticals Inc | 2.6B | -7.2x | --- |
Structure Therapeutics Inc | 2.6B | -19.6x | --- |
SpringWorks Therapeutics Inc | 2.7B | -7.0x | --- |
IDEAYA Biosciences Inc | 2.8B | -18.5x | --- |
MoonLake Immunotherapeutics | 2.5B | -51.2x | --- |
Intellia Therapeutics Inc | 2.3B | -4.5x | --- |
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and delivering transformative therapies for patients living with rare diseases. It markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for debilitating hemolytic anemia. Its lead product candidate in its genetically defined disease (GDD) portfolio, PYRUKYND (Mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the treatment of hemolytic anemias. The Mitapivat is an orally available small molecule and a potent activator of the pyruvate kinase R (PKR) enzymes. In addition, it is also evaluating mitapivat for the treatment of alpha- and beta- thalassemia and sickle cell disease (SCD) in ongoing clinical trials. The Company is also developing AG-946, a clinical-stage oral activator of PKR enzymes for the treatment of hemolytic anemias and other indications, including SCD.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.6B |
---|---|
Revenue (TTM) | $29.4M |
Shares Outstanding | 56.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.79 |
EPS | $-6.31 |
Book Value | $14.50 |
P/E Ratio | -7.2x |
Price/Sales (TTM) | 87.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,336.42% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.